中文名稱: 兔抗NFKBIB (Phospho-Ser23) 多克隆抗體
英文名稱: Anti-NFKBIB (Phospho-Ser23) rabbit polyclonal antibody
別 名: IKBB; TRIP9
相關(guān)類別: 一抗
儲 存: 冷凍(-20℃) 避光
宿 主: Rabbit
抗 原: NFKBIB (Phospho-Ser23)
反應(yīng)種屬: Human, Mouse, Rat
標(biāo) 記 物: Unconjugate
克隆類型: rabbit polyclonal
技術(shù)規(guī)格
Background: |
Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further IKBA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation. |
Applications: |
IHC |
Name of antibody: |
NFKBIB (Phospho-Ser23) |
Immunogen: |
Synthetic peptide of human NFKBIB (Phospho-Ser23) |
Full name: |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Phospho-Ser23) |
Synonyms: |
IKBB; TRIP9 |
SwissProt: |
Q15653 |
IHC positive control: |
Human breast carcinoma |
IHC Recommend dilution: |
50-100 |